Key Findings 1 Tirzepatide reduced major kidney events by 23% vs dulaglutide Events: 6.0% vs 7.6% HR 0.77 (95% CI 0.680.88), p=0.0002 The risk of the primary composite kidney outcomewas 23% lower with tirzepatide than with dulaglutide. 2 Benefits were consistent across CKD risk categories Lowtomoderate risk CKD: HR 0.70 Highrisk CKD: HR 0.79 3 Mechanistic drivers differed by CKD stage Lowtomoderate CKD: Less newonset macroalbuminuria Highrisk CKD: Slower eGFR decline This was primarily driven by a lower rate of new-onset persistent macroalbuminuria and a lower rate of eGFR decline. 4 eGFR decline was significantly slower with tirzepatide Overall difference: +0.29 mL/min/1.73 m per year Highrisk CKD: +0.93 mL/min/1.73 m per year 5 Albuminuria improved more with tirzepatide At 36 months, UACR reductions were greater across CKD categories
3 Gluten-Free Even if you dont have Celiac disease, a gluten-free diet can reduce intestinal irritation
[DOI] [PMC free article] [PubMed] [Google Scholar] 60.Christensen-Quick A., Lafferty M., Sun L., Marchionni L., DeVico A., Garzino-Demo A
Dose escalation schedules also influence your timeline
Users who follow a structured tirzepatide diet plan with attention to meal timing consistently report better sleep than those who eat without regard to when their last meal occurs
First Volunteer Receives Experimental Bundibugyo Vaccine health-wellness Can Hepatitis Be Completely Cured
